Research programme: heart disease - deCODE genetics/Pfizer
Latest Information Update: 05 Sep 2006
At a glance
- Originator deCODE genetics; Encode; Pfizer
- Developer Pfizer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 05 Sep 2006 Discontinued - Preclinical for Cardiovascular disorders in USA (unspecified route)
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 13 Feb 2002 New profile